Navigation Links
Frequently used biologic agents might cause acute liver injury
Date:4/29/2013

Bethesda, MD (April 29, 2013) A commonly used class of biologic response modifying drugs can cause acute liver injury with elevated liver enzymes, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Patients with inflammatory diseases such as Chron's disease or ulcerative colitis often are prescribed tumor necrosis factor-alpha (TNF-α) antagonists, which modify the body's response to infection. Patients with inflammatory arthropathies and selected dermatological diseases are also candidates to receive such compounds.

"TNF-α antagonists are extremely beneficial as therapies for several bowel, joint and skin inflammatory conditions," said Maurizio Bonacini, MD, AGAF, study author and associate clinical professor, University of California, San Francisco. "However, gastroenterologists, internists, rheumatologists and dermatologists all need to be aware of this potential complication and know how to diagnose it. They should conduct tests for autoimmunity early upon diagnosis of abnormalities to determine the proper path of care."

Researchers searched the U.S. Drug-Induced Liver Injury Network database and identified six well-characterized cases of drug-induced liver injury (DILI) in the setting of TNF-α antagonist therapy. Additionally, they reviewed 28 additional cases identified in PubMed. The researchers found acute liver injury in all cases, most frequently autoimmunity and hepatocellular injury, but mixed non-autoimmune patterns and cholestasis (blocked flow of bile from the liver) also occurred. No deaths were attributed to the liver injury; one patient required a liver transplant, which was attributed to pre-existing cirrhosis with superimposed DILI.

Of the TNF-α antagonists, infliximab-associated liver injury has been the best documented, most likely because of its earlier approval and more wide-s
'/>"/>

Contact: Rachel Steigerwald
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Frequently prescribed drug used in concerning ways with harmful side effects
2. UC Davis study finds stray-bullet shootings frequently harm women and children
3. Men Biologically Programmed to Steer Clear of Friends Wives
4. Dog Study Raises Prospect of Biological Pacemaker for Humans
5. Medicines quality workshop to address standards for microbiological contamination, bioburden control
6. Dr. Daniel Strader of Dallas Designer Smiles Receives Top Reviews as Local Dallas, TX Dentist for Biological Dentistry
7. Researchers discover biological diversity in triple-negative breast cancer
8. Mayo Clinic-led study unravels biological pathway that controls the leakiness of blood vessels
9. Ordinary heart cells become biological pacemakers with injection of a single gene
10. Cutting-edge approaches to ensuring biologic drug quality focus of forum on bioassays
11. Solving a biological mystery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... CO (PRWEB) , ... September 04, 2015 , ... Mile ... the ways in which a lack of funding for sidewalks, bike paths, and other ... the report, while the Denver region spends billions of dollars to expand public transit, ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... the surrounding communities, is launching a charity effort to provide for the family ... to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... three separate “Partner of the Year” awards at this year’s Microsoft Worldwide Partner ... Microsoft’s 2015 “Partner of the Year” Award Winner for Data Platform services, the ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mike Day, a former Navy ... compete in the Ironman World Championships in Kona on October 10th. , Mike is ... Brain Injury (TBI) through combat and the cutting-edge treatments that restore their quality of ...
(Date:9/4/2015)... ME (PRWEB) , ... September 04, 2015 , ... ... focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at ... , Speakers at the 2015 symposium are doctors and researchers at the top ...
Breaking Medicine News(10 mins):Health News:Missed Connections in Metro Denver Transit 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... used to repair the breastbone after it is intentionally broken ... technique uses a state-of-the-art adhesive that rapidly bonds to bone ... heal the breastbone in hours instead of weeks after open-heart ... and get back to full physical activities in days instead ...
... ... ... In lockstep with the nation,s focus on healthcare, Oprah Winfrey has for the first ... tourism." Introduced on Oprah.com Monday, November 9th, the segment presents medical tourism as a ...
... ... topic of Alzheimer,s prevention. , ... Naples, FL (PRWEB) November 12, 2009 -- Integrative neurologist, Dr. David ... on the topic of Alzheimer,s disease prevention. The conference will be held in Monaco, ...
... ... Senior Quality Lifestyles Corporation (SQLC), a Texas-based nonprofit developer of senior living ... Stayton at Museum Way. A 501(c)3 nonprofit life care retirement community, The ... located at Stayton Street and Museum Way in the Fort Worth Cultural ...
... ULURU Inc. (NYSE Alternext: ULU), ... portfolio of wound management and oral care products, today announced ... of its common stock at a price per share of ... resulting in gross proceeds of approximately $1.5 million. , Investors ...
... (LSE: SHP, Nasdaq: SHPGY ), the global ... examining emotional lability from Phase 3 study data with ... significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by ... Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 ...
Cached Medicine News:Health News:Surgeon 'gluing' the breastbone together after open-heart surgery 2Health News:Medical Tourism Hits Oprah.com 2Health News: Integrative Neurologist Breaks Ground in Alzheimer's Prevention 2Health News:Senior Quality Lifestyles Corporation Announces Completion of $164,855,000 in Financing for The Stayton at Museum Way 2Health News:Senior Quality Lifestyles Corporation Announces Completion of $164,855,000 in Financing for The Stayton at Museum Way 3Health News:ULURU Inc. to Raise $1.5 Million in Registered Direct Offering 2Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 2Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 3Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 4Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 5Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 6
(Date:9/3/2015)... , Sept. 3,  2015 About ... bio-artificial devices, which are implanted or integrated ... organs. These include artificial heart, kidney, pancreas, ... polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ... artificial organs. These organs are incorporated with ...
(Date:9/3/2015)... 3, 2015 About dry eye syndrome Dry ... to deficient tear production or quick tear evaporation or ... types: aqueous tear deficient dry eye and evaporative dry ... do not produce enough tears, whereas meibomian gland dysfunction ... to slow tear evaporation and maintain tear stability. The ...
(Date:9/3/2015)... Sept. 3, 2015  Ascendis Pharma A/S ... biotechnology company that applies its innovative TransCon ... today announced plans to present at several ... Healthcare Conference in BostonDate: , Thursday, September ... of America Merrill Lynch Global Healthcare Conference ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
... WIRE)--May 21, 2007 - Cougar Biotechnology,Inc. (OTCBB:CGRB) today ... on the Company's prostate cancer drug candidate CB7630,(abiraterone ... Annual Meeting, which is currently taking place,in Anaheim, ... A.,Yap from the Cancer Research UK Centre for ...
... 40/12.5 and 40/25 mg/day and Amlodipine +,Benazepril ... Society of,Hypertension Twenty-Second Annual Scientific Meeting, PARSIPPANY, ... data,presented today at the American Society of ... Chicago,demonstrated that the fixed-dose combination Benicar HCT,(olmesartan ...
Cached Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8
Spherical Burr for FR030R, 5 mm....
Cutting Burr with dental shank, tungsten carbide, 0,7 mm, ISO-No. 007, packing unit 10 pieces....
Hough Hough Burr-Saw for Crurotomy, 1 mm, ISO-No. 010....
"Rosen" burr, 0,7 mm, ISO-No. 007....
Medicine Products: